Cutaneous T-Cell Lymphoma

This is a type of T-cell lymphoma that affects the skin. It causes skin problems like rashes or growths. It's a specific form of T-cell lymphoma that spreads into the skin.

Condition

What people with Cutaneous T-Cell Lymphoma report

Every report comes from a Lived member, sent anonymously.

Have you tried PUVA Therapy for Cutaneous T-Cell Lymphoma?

NameHow it went

About Cutaneous T-Cell Lymphoma

What It Is

Cutaneous T-cell lymphoma (CTCL) is a group of blood cancers that show up first in the skin. It begins in T cells, a type of white blood cell that normally helps the immune system fight infection. In CTCL, abnormal T cells multiply and collect in the skin, causing rashes, raised areas or lumps. It is a type of non-Hodgkin lymphoma, but unlike most lymphomas it usually starts in the skin rather than in the lymph nodes. The most common type is mycosis fungoides. It typically begins as flat, dry, scaly pink or red patches, often on skin that is usually covered by clothing, and the patches are frequently very itchy. Over years, some people develop thicker raised plaques, and a smaller number develop tumors that can break open. Sezary syndrome is a less common, more serious type in which most of the skin becomes red, itchy and peeling, and lymphoma cells circulate in the blood. Other forms include lymphomatoid papulosis, which causes crops of bumps that heal on their own and is not life-threatening, and rare variants such as granulomatous slack skin. Because these types behave so differently, knowing the exact type matters as much as knowing that it is CTCL.

Causes & Risk Factors

In most people, there is no clear cause, and nothing a person did is known to bring it on. It is most often diagnosed in people in their 50s and 60s, although some types appear in younger adults and occasionally in children. It is more common in men than in women, and more common in Black people than in White people, for reasons that are not understood. A weakened immune system, such as from HIV (human immunodeficiency virus) infection or from medicines taken after an organ transplant, appears to raise the risk. A few viruses are linked to specific rare types; for example, human T-lymphotropic virus type 1 (HTLV-1) is tied to adult T-cell leukemia/lymphoma, which is most common in parts of Japan and the Caribbean. Most people with these risk factors never develop skin lymphoma.

How It's Diagnosed

Early mycosis fungoides can look almost exactly like eczema, psoriasis or a long-lasting drug or contact rash. Many people are treated for one of these for years before the diagnosis becomes clear, especially because the patches can come and go. A skin rash that keeps returning in the same pattern or does not respond as expected is often what leads a doctor to look further. The diagnosis is confirmed with a skin biopsy, in which a small piece of skin is removed under numbing medicine and examined by a pathologist. Special lab tests on the sample check which kind of immune cell is involved and whether the T cells are all copies of one abnormal cell, which points toward lymphoma rather than inflammation. Because early changes can be subtle, more than one biopsy, sometimes months apart, may be needed, and review by a pathologist experienced in skin lymphoma is valuable. Once CTCL is confirmed, staging shows how far it extends. Doctors estimate how much of the skin surface is involved, examine the lymph nodes, and use blood tests, including a count of Sezary cells (lymphoma cells in the blood). Scans or a lymph node biopsy may be done when the disease is more widespread. In the staging system for mycosis fungoides, stage IA means patches or plaques cover less than 10% of the skin, while higher stages involve more skin, tumors, lymph nodes, the blood or internal organs.

Treatment Options

For most people, CTCL can be controlled rather than cured. Treatment aims to clear or shrink skin lesions, relieve itching and keep the disease from progressing, and many people go through periods of remission and relapse that are treated again. The choice depends mainly on the type and stage, how much skin is involved and how much symptoms affect daily life. Early-stage mycosis fungoides is usually treated with skin-directed therapy. This includes strong corticosteroid creams, chemotherapy or retinoid gels applied to the skin, and phototherapy, in which the skin is exposed to ultraviolet light in a clinic several times a week over a course of treatment. One form, PUVA (psoralen plus ultraviolet A), combines ultraviolet A light with a light-sensitizing medicine called psoralen. Single lesions can be treated with targeted radiation, and total skin electron beam therapy treats the entire skin surface with radiation. These treatments often clear or improve the skin, but the disease commonly returns and treatment may need repeating. When the disease is widespread, involves the blood or does not respond to skin treatments, systemic therapies are added. Options include bexarotene, a vitamin A-related pill that slows lymphoma cell growth (it causes birth defects and must not be taken during pregnancy); interferon, which stimulates the immune system; and histone deacetylase (HDAC) inhibitors such as vorinostat and romidepsin. Antibody treatments include mogamulizumab, which helps the immune system clear lymphoma cells and is used after at least one earlier systemic treatment, and brentuximab vedotin, which carries a drug to cells displaying a protein called CD30. Extracorporeal photopheresis, in which some blood cells are removed, treated with ultraviolet light and returned, is used for advanced disease including Sezary syndrome. Chemotherapy, either applied to the skin or given as pills or infusions, is another option. For selected people with advanced or treatment-resistant disease, a stem cell transplant from a donor is the only potentially curative option, but it carries serious risks and is considered only after careful specialist evaluation. Supportive care matters at every stage. Gentle skin care, moisturizers, treatment for itching and prompt treatment of skin infections can make a large difference in comfort. Because CTCL is rare, care at or in consultation with a center experienced in cutaneous lymphoma is often recommended, and clinical trials are an option at many stages.

What to Expect

The course depends mostly on type and stage. Many people with early mycosis fungoides live with it for many years, often decades, and among people with very limited patches, most die of causes unrelated to the lymphoma. For them, CTCL often behaves like a long-term skin condition that flares and settles, with periods of treatment followed by monitoring. Roughly 1 in 5 people with early-stage disease eventually progress to a more advanced stage, which is why regular skin checks continue even when the skin looks clear. Advanced mycosis fungoides and Sezary syndrome are more serious. They tend to need ongoing systemic treatment, responses are often shorter, and the weakened immune system makes infections a real concern. Rarely, the lymphoma cells change into a faster-growing form (large cell transformation), which needs a change in treatment. Daily life is often shaped by the skin itself. Itching can disrupt sleep and concentration, and visible patches or peeling skin can affect comfort, clothing choices and self-confidence. Treatments such as phototherapy require frequent clinic visits for weeks or months. Follow-up visits usually include full skin checks, photographs to track changes, and blood tests, so that changes can be caught early.

When to Seek Help

See a doctor, ideally a dermatologist, if you have patches of scaly, itchy or discolored skin that last for months, keep returning in the same places, or do not improve with the treatment you were given for eczema or psoriasis. Ask about a biopsy if the diagnosis has never been confirmed. If you already have CTCL, contact your care team about new lumps on the skin, a patch that thickens or grows quickly, sores that break open, swollen lymph nodes, unexplained weight loss or night sweats, or itching that treatment no longer controls. Call your care team right away for fever or chills, or for skin that becomes hot, swollen, increasingly painful, crusted or oozing pus, or new painful blisters. In people with CTCL, especially those with open tumors or Sezary syndrome, a skin infection can spread into the blood and needs prompt treatment.

Questions to Ask Your Doctor

  1. 1.Which type and stage of cutaneous T-cell lymphoma do I have, and what does that mean for my outlook?
  2. 2.What is the goal of the treatment you are recommending, and how will we know if it is working?
  3. 3.Should my biopsy be reviewed, or my care coordinated, with a center that specializes in cutaneous lymphoma?
  4. 4.What can I do about the itching and skin care, and what signs of infection should I watch for?
  5. 5.How often will I need skin checks and blood tests if my disease is in remission?

Last reviewed • Oct 2026

Educational content, not medical advice.